Light therapy after radiation for inoperable airway tumors
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new light-activated therapy (interstitial photodynamic therapy) after palliative radiation to shrink inoperable airway tumors and improve breathing. It is for people with solid cancers that block the airway from the outside and cannot be removed with surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a solid tumor that is pressing on your airway from the outside and cannot be removed with surgery.
- You are able to receive standard palliative radiation therapy to the tumor.
- You have a performance status of 0, 1, 2, or 3 (able to do most daily activities with some help).
- Your blood clotting and platelet levels are within safe ranges.
- You are willing to use effective birth control if you or your partner could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to destroy lung tumors using a light-activated drug (5-ALA) and a special light during a bronchoscopy (a tube placed into the lungs). It may be an option if standard treatments have not worked or are not suitable for you.
This trial tests combining partial tumor radiation with immunotherapy for people with advanced lung adenocarcinoma who cannot have surgery or standard radiation. It may help those whose cancer has stopped responding to previous treatments.
This trial tests whether adding high-dose, targeted radiation to the usual treatment helps people with locally advanced, non-operable lung cancer live longer or better control the cancer. It may help shrink tumors in the chest and improve outcomes when surgery can’t be done.
This trial tests two types of radiation therapy combined with an immunotherapy drug called pembrolizumab before surgery for oral cavity cancer. The goal is to see if this combination can shrink the tumor and improve outcomes.
This study tests whether adding a special type of radiation to standard palliative radiation helps reduce symptoms like pain, shortness of breath, or bleeding. It's for people with tumors that can't be removed and are large.
This trial tests combining two types of radiation therapy with an immunotherapy drug for people with advanced solid tumors that have spread or come back. The goal is to see if this approach can help when standard treatments have stopped working or aren’t an option.
Hear when a new Malignant Solid Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.